AI Analysis AI Analysis of IMMP AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add IMMP to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Thursday for Immutep Ltd
(Updated on Jul 30, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 21, 2026 Loss -4.88%

The Immutep Ltd stock price fell by -0.263% on the last day (Thursday, 30th Jul 2026) from $0.381 to $0.380. During the last trading day the stock fluctuated 5.53% from a day low at $0.369 to a day high of $0.389. The price has fallen in 8 of the last 10 days and is down by -12.81% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -108 thousand shares and in total, 77 thousand shares were bought and sold for approximately $29.26 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -12.49% during the next 3 months and, with a 90% probability hold a price between $0.279 and $0.406 at the end of this 3-month period.

IMMP Signals & Forecast

There are few to no technical positive signals at the moment. The Immutep Ltd stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.385 and $0.400. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, July 13, 2026, and so far it has fallen -15.69%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Immutep Ltd stock

Immutep Ltd finds support from accumulated volume at $0.377 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0204 between high and low, or 5.53%. For the last week the stock has had daily average volatility of 5.97%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IMMP) For The Upcoming Trading Day Of Friday 31st

For the upcoming trading day on Friday, 31st we expect Immutep Ltd to open at $0.379, and during the day (based on 14 day Average True Range), to move between $0.367 and $0.392, which gives a possible trading interval of +/-$0.0253 (+/-6.90%) up or down from last closing price. If Immutep Ltd takes out the full calculated possible swing range there will be an estimated 6.90% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.377 (0.84%) than the resistance at $0.398 (4.69%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Immutep Ltd stock A Buy?

Immutep Ltd holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.177 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 31, 2026 - $0.379 ( 0.105%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

IMMP Performance

Trading levels for IMMP

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.400 5.27%
R2 0.392 3.21%
R1 0.387 1.95%
Price 0.380
S1 0.372 -2.16%
S2 0.367 -3.42%
S3 0.359 -5.48%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.445 17.06%
R2 0.436 14.85%
R1 0.398 4.69%
Price 0.380
S1 0.377 -0.84%
S2 0.369 -2.87%
S3 0.361 -4.87%

FAQ

What is the symbol for Immutep Ltd Stock and on which exchange is it traded?
The symbol for Immutep Ltd is IMMP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Immutep Ltd Stock?
Immutep Ltd holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Immutep Ltd Stock?
Immutep Ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Immutep Ltd Stock.

What's the current price of Immutep Ltd Stock?
As of the end of day on the Jul 30, 2026, the price of an Immutep Ltd (IMMP) share was $0.380.

What is the 52-week high and low for Immutep Ltd Stock?
The 52-week high for Immutep Ltd Stock is $3.53 and the 52-week low is $0.293.

What is the market capitalization of Immutep Ltd Stock?
As of the Jul 30, 2026, the market capitalization of Immutep Ltd is 55.972M.

When is the next earnings date for Immutep Ltd?
The upcoming earnings date for Immutep Ltd is Sep 02, 2026.
Click to get the best stock tips daily for free!
ABOUT IMMUTEP LTD
Immutep
Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as a chemoimmunotherapy combination for metastatic breast cancer. The company also develops TACTI-002, wh...
GOLDEN STAR
Ticker Change Signal Date
UNFI
$49.05
2.26% Jul 27
FOX
$50.81
3.78% Jul 27
BIIB
$202.19
3.48% Jul 24
A
AVS
$7.74
3.10% Jul 24
TSCO
$30.32
2.24% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE